ACAAI Annals Fellow-in-Training Award Program – ACAAI Member
The FIT Awards are for an original research or review paper written by a fellow-in-training (FIT) with the FIT as first or senior author.
Related Articles
Factors associated with the development of severe asthma
Severe asthma presents a major challenge to health care and negatively affects the quality of life of patients. Understanding the factors predicting the development of…
Dillon’s Law – ACAAI Member
Dillon’s Law incentivizes states to allow any trained individual to administer epinephrine in schools during emergencies.
The use of grocery-sourced real-food solutions in sublingual immunotherapy for food allergies
Sublingual immunotherapy (SLIT) is a safe, effective therapy for the treatment of food allergy. Studies demonstrating SLIT efficacy have primarily used pharmaceutical glycerinated food extracts…
The August issue of Annals focuses on eosinophilic esophagitis – ACAAI Member
Three different reviews highlight important aspects in the diagnosis, treatment and natural history of EoE.
ACAAI Annals Fellow-in-Training Award Program – ACAAI Member
The FIT Awards are for an original research or review paper written by a fellow-in-training (FIT) with the FIT as first or senior author.
Can ChatGPT provide parent education for oral immunotherapy?
Oral Immunotherapy (OIT) has exhibited great potential in the treatment of food allergy. However, there is no global consensus on best practices of OIT. Parents…
Management of indolent mastocytosis and mast cell activation syndrome: A clinical yardstick
Knowledge and understanding of mast cell biology and mast cell disorders has increased in the past several years, with new classifications of diseases for both…
ACAAI Annals Fellow-in-Training Award Program – ACAAI Member
The FIT Awards are for an original research or review paper written by a fellow-in-training (FIT) with the FIT as first or senior author.
Weighing real-world studies when choosing a biologic for asthma
The past decade has seen a proliferation in biologic therapies for moderate to severe asthma, with 5 therapies gaining US Food and Drug Administration (FDA)…
Sleep disruption in chronic rhinosinusitis improves using exhalation-delivery nasal steroid therapy
Chronic rhinosinusitis is a common inflammatory condition that often leads to significant sleep disturbances, negatively affecting quality of life. Although intranasal steroids are a standard…